Sichuan Kelun Pharmaceutical Co Ltd (002422) — Financial Flexibility Index
Sichuan Kelun Pharmaceutical Co Ltd (002422) has a Financial Flexibility Index of 0.08x as of September 2025. Free cash flow of CN¥930.89 Million (operating CF CN¥537.31 Million minus capex CN¥393.58 Million) represents 0% of total liabilities (CN¥11.48 Billion). Check strategic asset allocation of Sichuan Kelun Pharmaceutical Co Ltd to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Sichuan Kelun Pharmaceutical Co Ltd Financial Flexibility Index (2007–2025)
Historical Financial Flexibility Index trend for Sichuan Kelun Pharmaceutical Co Ltd across 19 annual periods. See Sichuan Kelun Pharmaceutical Co Ltd (002422) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Sichuan Kelun Pharmaceutical Co Ltd (2007–2025)
Year-by-year free cash flow to debt coverage for Sichuan Kelun Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see Sichuan Kelun Pharmaceutical Co Ltd stock valuation.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.40x | CN¥4.26 Billion | CN¥2.64 Billion | CN¥10.54 Billion | ▼ -30.7% |
| 2024 | 0.58x | CN¥6.17 Billion | CN¥4.49 Billion | CN¥10.58 Billion | ▲ +10.3% |
| 2023 | 0.53x | CN¥7.11 Billion | CN¥5.34 Billion | CN¥13.44 Billion | ▲ +127.8% |
| 2022 | 0.23x | CN¥4.02 Billion | CN¥3.13 Billion | CN¥17.33 Billion | ▲ +5.3% |
| 2021 | 0.22x | CN¥3.84 Billion | CN¥2.85 Billion | CN¥17.41 Billion | ▲ +15.0% |
| 2020 | 0.19x | CN¥3.45 Billion | CN¥2.22 Billion | CN¥18.01 Billion | ▼ -5.1% |
| 2019 | 0.20x | CN¥3.55 Billion | CN¥2.22 Billion | CN¥17.58 Billion | ▼ -22.7% |
| 2018 | 0.26x | CN¥4.28 Billion | CN¥2.95 Billion | CN¥16.40 Billion | ▲ +56.0% |
| 2017 | 0.17x | CN¥2.68 Billion | CN¥1.20 Billion | CN¥16.01 Billion | ▼ -35.4% |
| 2016 | 0.26x | CN¥3.09 Billion | CN¥1.73 Billion | CN¥11.94 Billion | ▼ -3.9% |
| 2015 | 0.27x | CN¥3.08 Billion | CN¥1.24 Billion | CN¥11.42 Billion | ▼ -30.6% |
| 2014 | 0.39x | CN¥3.98 Billion | CN¥1.22 Billion | CN¥10.23 Billion | ▼ -7.0% |
| 2013 | 0.42x | CN¥3.31 Billion | CN¥1.05 Billion | CN¥7.92 Billion | ▼ -22.9% |
| 2012 | 0.54x | CN¥3.18 Billion | CN¥402.77 Million | CN¥5.87 Billion | ▼ -41.6% |
| 2011 | 0.93x | CN¥2.35 Billion | CN¥342.93 Million | CN¥2.53 Billion | ▲ +105.9% |
| 2010 | 0.45x | CN¥796.51 Million | CN¥149.29 Million | CN¥1.77 Billion | ▲ +50.0% |
| 2009 | 0.30x | CN¥525.98 Million | CN¥250.69 Million | CN¥1.75 Billion | ▼ -1.8% |
| 2008 | 0.31x | CN¥447.66 Million | CN¥221.08 Million | CN¥1.47 Billion | ▼ -2.6% |
| 2007 | 0.31x | CN¥343.47 Million | CN¥168.42 Million | CN¥1.10 Billion | — |